TAK fundamentals
An in-depth look to Takeda Pharmaceutical Company Limited operating, investing, and financing activities
TAK free cash flow for Q3 23 is 481.21 M USD. For 2022, TAK free cash flow was 5.44 B USD and operating cash flow was 6.47 B USD.
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
TTM